HIV 1/2 4th Gen, RFLX Conf
Other names: HIV 1/2 AB/ag Rflx conf, HIV 1/2 ag/AB combo, Human immunodeficiency virus
Human Immunodeficiency Virus (HIV) is categorized into two distinct types: HIV-1 and HIV-2. Both are retroviruses that attack the body's immune system, but they have differences in their geographical prevalence, transmission rates, and progression to Acquired Immunodeficiency Syndrome (AIDS).
HIV-1: This is the most common type of HIV and is found worldwide. It's responsible for the vast majority of HIV infections globally. HIV-1 is characterized by its rapid transmission and progression. It is more aggressive and infects cells faster than HIV-2, leading to a quicker decline in immune function if left untreated. HIV-1 is divided into four groups: M (Main), O (Outlier), N (Non-M, Non-O), and P, with Group M responsible for the majority of infections worldwide. Further, Group M is divided into multiple subtypes and circulating recombinant forms (CRFs).
HIV-2: This type is less common and is predominantly found in West Africa, with some cases in India and Europe. Compared to HIV-1, HIV-2 is transmitted less efficiently, particularly from mother to child and through heterosexual contact. The progression of HIV-2 to AIDS is generally slower, and it may have a longer asymptomatic stage. HIV-2 is also less responsive to certain antiretroviral therapies, requiring specific treatment regimens.
In terms of diagnosis, the 4th generation HIV tests are capable of detecting both HIV-1 and HIV-2. These tests look for both antibodies (the body’s immune response to the virus) and antigens (specific parts of the virus; in the case of HIV, the p24 antigen is commonly targeted). The ability to detect antigens allows these tests to identify HIV infections earlier than antibody-only tests.
The management of HIV involves antiretroviral therapy (ART), which is effective for both types, although the specific treatment regimen may vary depending on whether it's HIV-1 or HIV-2. ART works by reducing the viral load in the body to undetectable levels, improving the quality of life and life expectancy of infected individuals, and significantly reducing the risk of transmission.
Understanding the differences between HIV-1 and HIV-2 is crucial for effective treatment and epidemiological control. Both types of HIV can lead to the weakening of the immune system, making individuals more susceptible to other infections and diseases. Early detection and appropriate treatment are key to managing the infection and preventing its spread.
The management of HIV involves antiretroviral therapy (ART), which is effective for both types, although the specific treatment regimen may vary depending on whether it's HIV-1 or HIV-2. ART works by reducing the viral load in the body to undetectable levels, improving the quality of life and life expectancy of infected individuals, and significantly reducing the risk of transmission.
Understanding the differences between HIV-1 and HIV-2 is crucial for effective treatment and epidemiological control. Both types of HIV can lead to the weakening of the immune system, making individuals more susceptible to other infections and diseases. Early detection and appropriate treatment are key to managing the infection and preventing its spread.
The marker "HIV 1/2 4th Gen, RFLX Conf" on a sexually transmitted disease (STD) test panel refers to the fourth-generation testing for Human Immunodeficiency Virus (HIV) Types 1 and 2, with reflex to confirmatory testing. This advanced testing methodology significantly enhances the early detection of HIV, the virus responsible for Acquired Immunodeficiency Syndrome (AIDS). Fourth-generation tests are designed to detect both HIV antigens (specifically, the p24 antigen which appears soon after infection and before antibodies are made) and antibodies (the immune response to the virus). This dual detection approach allows for the identification of acute HIV infections earlier than previous generation tests that only detected antibodies.
The "RFLX Conf" part of the marker indicates that if the initial test is reactive, indicating the possible presence of HIV, the sample will automatically undergo additional confirmatory testing. This typically involves an HIV-1/HIV-2 antibody differentiation immunoassay to confirm the presence of HIV and determine whether it is type 1 or type 2. In some cases, if the differentiation assay is inconclusive, a nucleic acid test (NAT) may be performed to detect the virus's genetic material directly.
The inclusion of this test in STD panels is critical due to the asymptomatic nature of early HIV infection and the significant public health implications of undiagnosed HIV. Early detection through the fourth-generation test allows for timely initiation of antiretroviral therapy (ART), which is crucial for managing HIV, reducing the risk of transmission, and improving long-term health outcomes. Additionally, early intervention has been shown to significantly reduce the risk of HIV-related complications and transmission to others, underscoring the importance of including this test in comprehensive STD testing and early intervention strategies.
NOTE: The performance of this assay has not been established for individuals younger than 2 years of age. Nearly all infants born to HIV-infected mothers passively acquire maternal antibody and may test antibody positive until 18 months regardless of infection status. Definitive diagnosis requires other assays, including HIV nucleic acid tests.
All Your Lab Results.
One Simple Dashboard.
Import, Track, and Share Your Lab Results Easily
Import, Track, and Share Your Lab Results
Import lab results from multiple providers, track changes over time, customize your reference ranges, and get clear explanations for each result. Everything is stored securely, exportable in one organized file, and shareable with your doctor—or anyone you choose.
Cancel or upgrade anytime
Laboratories
Bring All Your Lab Results Together — In One Place
We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.
Pricing Table
Gather Your Lab History — and Finally Make Sense of It
Finally, Your Lab Results Organized and Clear
Personal plans
$79/ year
Advanced Plan
Access your lab reports, explanations, and tracking tools.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 5 reports entered for you
- Cancel or upgrade anytime
$250/ once
Unlimited Account
Pay once, access everything—no monthly fees, no limits.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 10 reports entered for you
- No subscriptions. No extra fees.
$45/ month
Pro Monthly
Designed for professionals managing their clients' lab reports
- Import lab results from any provider
- Track lab results for multiple clients
- Customize reference ranges per client
- Export lab histories and reports
- Begin with first report entered by us
- Cancel or upgrade anytime
About membership
What's included in a Healthmatters membership
Import Lab Results from Any Source
See Your Health Timeline
Understand What Your Results Mean
Visualize Your Results
Data Entry Service for Your Reports
Securely Share With Anyone You Trust
Let Your Lab Results Tell the Full Story
Once your results are in one place, see the bigger picture — track trends over time, compare data side by side, export your full history, and share securely with anyone you trust.
Bring all your results together to compare, track progress, export your history, and share securely.
What Healthmatters Members Are Saying
Frequently asked questions
Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.
- Individuals who want to track and understand their health over time.
- Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.
With a Healthmatters account, you can:
- Upload lab reports from any lab
- View your data in interactive graphs, tables, and timelines
- Track trends and monitor changes over time
- Customize your reference ranges
- Export and share your full lab history
- Access your results anytime, from any device
Professionals can also analyze client data more efficiently and save time managing lab reports.
Healthmatters.io personal account provides in-depth research on 10000+ biomarkers, including information and suggestions for test panels such as, but not limited to:
- The GI Effects® Comprehensive Stool Profile,
- GI-MAP,
- The NutrEval FMV®,
- The ION Profile,
- Amino Acids Profile,
- Dried Urine Test for Comprehensive Hormones (DUTCH),
- Organic Acids Test,
- Organix Comprehensive Profile,
- Toxic Metals,
- Complete Blood Count (CBC),
- Metabolic panel,
- Thyroid panel,
- Lipid Panel,
- Urinalysis,
- And many, many more.
You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.
If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.
We implement proven measures to keep your data safe.
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.